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debster defines backbone as “a main support or mainstay.”
nterventional cardiology has indeed become the backbone
f modern cardiovascular medicine, but this was not always
rue. During its formative years, beginning with the initial
escription in September 1977, “interventional cardiology”
as framed as a technique characterized by three major
ualities: 1) it was initially considered in only a small
umber of highly selected patients and lesions, 2) failure
ccurred in approximately 33% of even these selected
atients and was unpredictable, and 3) the failure mode
ften was awful, complicated by intractable ischemia, myo-
ardial infarction, need for emergency coronary artery by-
ass graft surgery, and even mortality (1). Only a wildly
ptimistic visionary could have foretold or imagined the
rominent position the technique has come to assume as the
ominant revascularization strategy for the treatment of
oronary artery, peripheral, and cerebrovascular disease (2).
What happened along the way to account for this
evolution? There have been dramatic changes in equipment
rom big, bulky devices that were difficult or impossible to
eliver to non-flexible delivery devices that can reach as far
s our imagination can take us. Current equipment includes
ighly sophisticated four-component devices marrying a
alloon delivery system, a metallic stent, a carrier polymer,
nd a drug. This creative combination has revolutionized
he field.
Other key changes happened along the way, perhaps the
ost important of which was a modification in mindset so
hat physicians demonstrated that they could successfully
ork less invasively—percutaneously—within the vascular
ree. This “light bulb moment” has led to the development
f invasive electrophysiologic procedures, such as mapping
nd ablation, percutaneous application of technology to
reat valvular heart disease, and application of percutaneous
echnologies to treat peripheral arterial disease and now
erebrovascular disease (2). Having broken that barrier,
nvasive percutaneous methods initially introduced by inter-
entional cardiologists should become the treatment of
hoice for a multiplicity of cardiovascular conditions. tThe wholesale acceptance that interventional cardiology
ow enjoys as a core practice component has taken nearly 30
ears of constant innovation and daring to accomplish.
here have been critical concerns to allay; among them,
ow to demonstrate effectiveness as well as safety and how
o train cardiologists to perform these sometimes risky
rocedures. Interventional cardiologists again have led the
ay. First, we conducted arguably the most comprehensive
arge-scale scientific trials in the history of medicine to
valuate the evidence behind the practice (1). Second,
nterventional cardiologists created training and education
rograms so that percutaneous coronary intervention can be
pplied for the greatest common good (for example,
ruentzig instituted closed-circuit televised demonstration
ourses, the first of which was held in 1978 with 28
hysicians in attendance) (1).
The American College of Cardiology (ACC) has been
eavily involved in both aspects of overcoming these barri-
rs. The ACC has showcased interventional cardiology in
xtramural and intramural courses and at its Annual Scien-
ific Sessions since the early 1980s, demonstrating the
cientific underpinnings of the practice. And the ACC’s
fforts to develop high-quality educational and training
rograms—crucial missions of the ACC—have been piv-
tal. To this end, the College has committed significant
nancial, member, and staff resources to developing a new
op-flight intervention meeting in co-sponsorship with the
ociety for Angiography and Intervention (SCAI). Now
nown as Innovation in Intervention: i2 Summit 2006, this
hree-day annual meeting will offer concentrated education,
imulation, laptop learning, and networking that will run
oncurrently with ACC ‘06, March 11 to 14, 2006, in
tlanta, Georgia. All of its many pieces have been carefully
ssembled by interventionalists to meet your special needs,
ased on unbiased research.
Education requires multiple components—needs assess-
ent, learner objectives, available teaching aids, curriculum
evelopment, personnel, and required resources. In 2004,
he ACC engaged a consulting company to assess how the
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rograms. Given the size of the ACC’s interventional
onstituency—nearly one-quarter of college members clas-
ify themselves as interventional cardiologists—this under-
aking had great importance (3). Interventional members
anted comprehensive, detailed, but balanced offerings
aturated with science, technical details, and practical tips
ut relatively free of commercial bias. They wanted an
xpert faculty who were dedicated to the art and science and
ho could communicate freely and fully. They wanted live
ases, simulation, case-based approaches, complication
anagement, tips and tricks, and late-breaking clinical
rials. They wanted debates and controversy but also con-
ensus and guidelines. They wanted to know where they are
ow and where they are going. Finally, they wanted “one-
top shopping” so they could be efficient with their learning
ime.
In response to this rather lengthy and robust request for
menu, what did the ACC leadership say? A resounding
Yes!” And so, Innovation in Intervention: i2 Summit 2006
as born and will bring those wishes to life through a
nique combination of needs-based knowledge, practical
nnovation, and unparalleled networking.
Everything asked for, i2 Summit is serving. It will have
ive cases from hand-picked sites that will focus on how to
o things and with what approach. It will provide virtual- 3eality simulators to teach new approaches and complication
anagement. It will report late-breaking clinical trials—the
atest and greatest. There will be core curriculum lectures on
athophysiology, adjunctive therapy, devices, and patient
nd lesion selection. There will be complication manage-
ent, video-taped cases, team training, radiation safety, and
anagement and treatment of acute coronary syndromes.
here will be controversy and consensus. There will be
tate-of-the-art lectures in what we have today and what we
ill have tomorrow. There will be lectures on how we image
nd how we decide on what to treat, how to treat it, and
hen results of that treatment. There will be industry
xhibits and expert faculty from around the world who are
ager and available. All these things in one place, at one
ime. One-stop shopping never sounded so good. Be there.
t is the start of something big.
ddress correspondence to: Dr. Pamela S. Douglas, American
ollege of Cardiology, c/o Cathy Lora, 9111 Old Georgetown
oad, Bethesda, Maryland 20814-1699.
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